All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
WASHINGTON – As economic woes continue to rattle Europe, many advocacy groups are looking to the U.S. to increase its funding of global R&D for HIV/AIDS, malaria and tuberculosis (TB).
